EDITOR-IN-CHIEF: KAI ROSSEN H. Lundbeck A/S Ottiliavej 9 2500 Valby, Denmark + 4536301311
[email protected] ASSOCIATE EDITOR Qilong Shen Shanghai Institute of Organic Chemistry, CAS
[email protected] EDITORIAL ADVISORY BOARD Stefan Abele Actelion Pharmaceuticals, Ltd., Switzerland
Donald Hou Chempartner Life Sciences, PR China
Matthias Beller Leibniz Institute for Catalysis, e.V., Germany
Guy Humphrey
Stephane Caron Pfizer Worldwide R&D, U.S.A.
Dhileep Krishnamurthy
Merck & Co. Inc., U.S.A.
Piramal Enterprises Ltd., India David A. Conlon Bristol-Myers Squibb, U.S.A.
David Lathbury
Fridtjof Schröder Givaudan Schweiz AG, Switzerland
Christian H. Senanayake Boehringer Ingelheim Pharmaceuticals, Inc., U.S.A.
Hong Shen Roche R&D Center (China) Ltd, China
Kazuhiko Takahashi Sumitomo Dainippon Pharma Co., Ltd., Japan
Astute Chemical Development Madeleine Delamare Merial, France
Consultancy Ltd., U.K. Steven A. Weissman Lexicon Pharmaceuticals, U.S.A. Zhen Li
Claire Francis Scientific Update Ltd., U.K.
Xiaoyong Fu WuXi Apptec, China
Arrowhead Research Corporation, U.S.A.
Katherine Wheelhouse GlaxoSmithKline Medicines Research Centre, U.K.
Beth Lorsbach Dow AgroSciences LLC, U.S.A.
Atsuhiko Zanka Takeda Pharmaceutical Co., Ltd., Japan
Soo Bong Han Korea Research Institute of Chemical Technology, South Korea
Jaan Pesti Gelest, Inc., U.S.A.
Tony Zhang Eli Lilly and Company, U.S.A.
Stefan Hildbrand F. Hoffmann-La Roche Ltd., Switzerland
Yogesh S. Sanghvi
Jianrong (Steve) Zhou Nanyang Technological University, Singapore
Rasayan, Inc., U.S.A.
